BIOTALYS NV (BTLS.BR) Stock Price, Quote, News and Overview

What is the stock price of BIOTALYS NV today?

The current stock price of BTLS.BR is 3.05 EUR. The price increased by 2.35% in the last trading session.

What is the ticker symbol for BIOTALYS NV stock?

The exchange symbol of BIOTALYS NV is BTLS and it is listed on the Euronext Brussels exchange.

On which exchange is BTLS.BR stock listed?

BTLS.BR stock is listed on the Euronext Brussels exchange.

What is the price forecast or stock price prediction for BIOTALYS NV stock?

8 analysts have analysed BTLS.BR and the average price target is 6.58 EUR. This implies a price increase of 115.7% is expected in the next year compared to the current price of 3.05. Check the BIOTALYS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is BIOTALYS NV worth?

BIOTALYS NV (BTLS.BR) has a market capitalization of 114.28M EUR. This makes BTLS.BR a Micro Cap stock.

How many employees does BIOTALYS NV have?

BIOTALYS NV (BTLS.BR) currently has 75 employees.

What are the support and resistance levels for BIOTALYS NV (BTLS.BR) stock?

BIOTALYS NV (BTLS.BR) has a support level at 3.03 and a resistance level at 3.05. Check the full technical report for a detailed analysis of BTLS.BR support and resistance levels.

Is BIOTALYS NV (BTLS.BR) expected to grow?

The Revenue of BIOTALYS NV (BTLS.BR) is expected to grow by 233.33% in the next year. Check the estimates tab for more information on the BTLS.BR EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy BIOTALYS NV (BTLS.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of BTLS.BR, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of BTLS.BR, evaluating the profitability, health, valuation and growth aspects
• BIOTALYS NV (BTLS.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• BIOTALYS NV (BTLS.BR) Sales and EPS estimates to see what analysts future expectations are.
• BIOTALYS NV (BTLS.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• BIOTALYS NV (BTLS.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
• BIOTALYS NV (BTLS.BR) Stock Chart to make your own analysis
• BIOTALYS NV (BTLS.BR) Latest news and press-releases to stay up to date.

Does BIOTALYS NV (BTLS.BR) stock pay dividends?

BTLS.BR does not pay a dividend.

What is the Price/Earnings (PE) ratio of BIOTALYS NV (BTLS.BR)?

BIOTALYS NV (BTLS.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).

ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. BTLS.BR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 11.74% compared to the year before.

ChartMill assigns a Buy % Consensus number of 88% to BTLS.BR. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 1.32% and a revenue growth 233.33% for BTLS.BR